🇺🇸 FDA
Pipeline program

Desvenlafaxine Succinate

Pristiq-2013

Approved small_molecule active

Quick answer

Desvenlafaxine Succinate for Vascular Depression is a Approved program (small_molecule) at Grace Therapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
Grace Therapeutics
Indication
Vascular Depression
Phase
Approved
Modality
small_molecule
Status
active

Clinical trials